Omeros (OMER) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.76% |
| Dec 31, 2025 | 16.00% |
| Sep 30, 2025 | 23.14% |
| Jun 30, 2025 | 1.55% |
| Mar 31, 2025 | -4.90% |
| Dec 31, 2024 | 21.08% |
| Sep 30, 2024 | -17.65% |
| Jun 30, 2024 | -34.37% |
| Mar 31, 2024 | -12.04% |
| Dec 31, 2023 | -12.94% |
| Sep 30, 2023 | -5.22% |
| Jun 30, 2023 | -5.25% |
| Mar 31, 2023 | -5.40% |
| Dec 31, 2022 | -22.08% |
| Sep 30, 2022 | -47.34% |
| Jun 30, 2022 | -23.25% |
| Mar 31, 2022 | -20.75% |
| Dec 31, 2021 | -49.02% |
| Sep 30, 2021 | -9.88% |
| Jun 30, 2021 | -31.63% |
| Mar 31, 2021 | -19.23% |
| Dec 31, 2020 | -36.02% |
| Sep 30, 2020 | -18.09% |
| Jun 30, 2020 | -14.77% |
| Mar 31, 2020 | -9.39% |
| Dec 31, 2019 | -39.61% |
| Sep 30, 2019 | 1.85% |
| Jun 30, 2019 | 3.91% |
| Mar 31, 2019 | -8.72% |
| Dec 31, 2018 | -11.15% |
| Sep 30, 2018 | -23.35% |
| Jun 30, 2018 | -20.06% |
| Mar 31, 2018 | -23.55% |
| Dec 31, 2017 | -16.56% |
| Sep 30, 2017 | 10.10% |
| Jun 30, 2017 | -11.03% |
| Mar 31, 2017 | -12.46% |
| Dec 31, 2016 | -6.65% |
| Sep 30, 2016 | -16.22% |
| Jun 30, 2016 | -18.54% |
| Mar 31, 2016 | -25.36% |
| Dec 31, 2015 | -16.33% |
| Sep 30, 2015 | -21.10% |
| Jun 30, 2015 | -16.08% |